Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...
WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction ...
Wall Street also was waiting to see whether President Donald Trump would follow through on his pledge to enact tariffs on ...
Truist Financial analyst Joon Lee maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today. The company’s shares closed ...
On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...